Kingworld Medicines Group Ltd. has announced the resignation of Mr. Zhang Jianbin as an independent non-executive director, chairman of the remuneration committee, and a member of both the audit and nomination committees, effective 1 August 2025. Dr. Chu Xiaoping will take over as the chairman of the remuneration committee on the same date.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.